Reuters
0
The risk of infection fell 90% by two weeks after the second shot
J&J pitched vaccine makers industrywide probe on blood clots: WSJ
Only AstraZeneca accepted Johnson & Johnson’s pitch, while Pfizer and Moderna declined, sources told the WSJ.
J&J pitched vaccine makers industrywide probe on blood clots: WSJ - Al Jazeera English
Only AstraZeneca accepted Johnson & Johnson’s pitch, while Pfizer and Moderna declined, sources told the WSJ.
In Similar Category
Marcia Dunn
10
SpaceX's futuristic Starship looked like it aced a touchdown Wednesday, but then exploded on the landing pad with so much force that it was hurled int...
Rapidly rising producer prices, driven by higher energy costs, raise concerns of accelerating global inflation.
New Mexico Democratic Gov. Michelle Lujan Grisham said during Wednesday's event that President Biden's moratorium pausing oil and gas leasing on feder...
A global company has stepped in to solve quite a “coinundrum” for a Georgia man. When Bellevue, Washington-based Coinstar heard about his predicament...
Canadians should scoop up TSX stocks like Kinaxis Inc. (TSX:KXS) and others as this bleak winter draws to a close.
From Al Jazeera English
The US Department of Labor said Thursday that applications for benefits increased by 16,000 from 728,000 a week earlier.
The US Treasury Department said Friday that no country currently meets the US criteria as a manipulator.
The group wants the US government to allocate funds for chip makers to expand production to cater to the auto sector.
‘It was time to get in the boats and protect the people, not check the inspection records,’ the Fed’s Chairman said.
Al Jazeera
16
US condemns China’s proposed veto powers on Hong Kong’s selection of politicians, calling it direct attack on autonomy.
Ukraine and Canada condemn Iranian account of the shooting down of airliner that killed 176 people aboard.